Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations
Clinical trial NCT01777529 · COMPLETED
Trial details
- NCT number
- NCT01777529
- Sponsor
- The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-01-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.